Role of 5 alpha-reductase inhibitors in the management of prostate cancer
Author:
Publisher
Informa UK Limited
Subject
Geriatrics and Gerontology,General Medicine
Reference49 articles.
1. Emerging minimally invasive techniques for treating localized prostate cancer
2. CHEMOPREVENTION OF PROSTATE CANCER IN MEN AT HIGH RISK: RATIONALE AND DESIGN OF THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) TRIAL
3. Treatment with finasteride following radical prostatectomy for prostate cancer
4. Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial
5. EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Incidence and risk factors of prostate cancer among the Northern and Eastern parts of the United Arab Emirates population;The Prostate;2023-11-15
2. Prostate cancer is not just a man’s concern — the use of PSA screening in transgender women;Nature Reviews Urology;2023-05-22
3. Novel multifunctional nanocarrier-mediated codelivery for targeting and treatment of prostate cancer;Nanomaterials for Drug Delivery and Therapy;2019
4. Precision Medicine Advancements Using Whole Genome Sequencing, Noninvasive Whole Body Imaging, and Functional Diagnostics;2018-12-17
5. Drugs for benign prostatic hypertrophy;Australian Prescriber;2018-10-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3